Overview


Artificial intelligence (AI) refers to the ability of a computer-controlled robot or digital computer to perform tasks that are commonly associated with intelligent beings. This term is often used to describe the development of systems that have the intellect of humans. It includes the ability to reason, find meaning, generalize, and learn from past experiences. Any machine with human-like characteristics, such as problem-solving and learning, may be used for this term. Artificial intelligence's best characteristic is its ability to reason and take the most effective actions in order to achieve a goal. Artificial Intelligence (AI) includes machine learning (ML). It refers to the idea that computer programs can automatically adapt to and learn from new data, without human assistance. This automatic learning is possible through deep learning techniques that absorb large amounts of unstructured data, such as text and images.

Artificial intelligence can be used to perform tasks such as speech recognition and learning, planning, problem-solving, or planning. It can also be used in drug screening. Drug screening involves chemical analysis that is used to screen for drug abuse. This is an important step because drug abuse can have serious consequences for brain health and behavior. This is used in workplaces to prevent hiring drug addicts and provide safe work environments for employees. Medical technology professionals have been interested in AI for the past few decades. Many companies and research labs have developed these technologies for clinical applications. Artificial intelligence allows for quicker screening of drug abusers and also helps in the treatment of drug addicts. The rise in alcohol consumption, the use of illicit drugs and narcotics across the globe, strict government drug screening laws, the adoption of Al systems, and technological advances in the field of drug screening will drive demand for artificial intelligence. This is expected to increase the market for artificial intelligence in drug screening. Other factors that will drive growth include Al's precise results in drug screening, rising healthcare spending, and economic development around the world. The market growth is also supported by the increase in government funding to combat drug trafficking. However, a lack of clarity in regulatory matters and resistance among healthcare professionals to using Al-based technology are likely to hinder the growth of artificial intelligence in drug screening markets. AI solutions can be used to eliminate potential obstacles, speed up the clinical trial cycle, and increase productivity and accuracy. Other factors that will drive market growth over the forecast period include technological advancements in AI for drug discoveries and a reduction in the total time required for drug discovery. Market growth will be impeded by inconsistency and low-quality data. Market growth will also be impeded by the high costs associated with technology and technical limitations.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Artificial Intelligence in Drug Screening Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Artificial Intelligence in Drug Screening Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Alere Inc
  • Drgerwerk AGCo. KGA
  • Abbott Laboratories
  • Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc
  • Danaher Corporation
  • Quest Diagnostics
  • Express Diagnostics International Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Immunoassay Analyzers
  • Breathanalyzer
  • Rapid test Devices
  • Assay kits
  • Chromatography Instruments

By Sample Type

  • Urine
  • Hair
  • Oral
  • Others

By End User

  • Workplace
  • Hospital
  • Criminal Justice

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Artificial Intelligence in Drug Screening Market By Product Type, By Sample Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Artificial Intelligence in Drug Screening Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Artificial Intelligence in Drug Screening Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Artificial Intelligence in Drug Screening Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Artificial Intelligence in Drug Screening Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immunoassay Analyzers
        2. Breathanalyzer
        3. Rapid test Devices
        4. Assay kits
        5. Chromatography Instruments

  • 8.   Artificial Intelligence in Drug Screening Market, By Sample Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Urine
        2. Hair
        3. Oral
        4. Others

  • 9.   Artificial Intelligence in Drug Screening Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Workplace
        2. Hospital
        3. Criminal Justice

  • 10.   North America Artificial Intelligence in Drug Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Artificial Intelligence in Drug Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Artificial Intelligence in Drug Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Artificial Intelligence in Drug Screening Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Alere Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Drgerwerk AGCo. KGA
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abott laboratories
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hoffmann-La Roche AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Thermo Fisher Scientific Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Danaher Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Quest Diagnostics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Express Diagnostics International Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients